These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 21903370

  • 21. Effects of budesonide and formoterol on allergen-induced airway responses, inflammation, and airway remodeling in asthma.
    Kelly MM, O'Connor TM, Leigh R, Otis J, Gwozd C, Gauvreau GM, Gauldie J, O'Byrne PM.
    J Allergy Clin Immunol; 2010 Feb; 125(2):349-356.e13. PubMed ID: 19969339
    [Abstract] [Full Text] [Related]

  • 22. Inflammatory and functional effects of increasing asthma treatment with formoterol or double dose budesonide.
    Menezes MB, Teixeira AL, Terra Filho J, Vianna EO.
    Respir Med; 2008 Oct; 102(10):1385-91. PubMed ID: 18632258
    [Abstract] [Full Text] [Related]

  • 23. Combination inhalers containing inhaled corticosteroids and long-acting beta2-agonists: improved clinical efficacy and dosing options in patients with asthma.
    Ankerst J.
    J Asthma; 2005 Nov; 42(9):715-24. PubMed ID: 16316864
    [Abstract] [Full Text] [Related]

  • 24. Biochemical interaction between effects of beclomethasone dipropionate and salbutamol or formoterol in sputum cells from mild to moderate asthmatics.
    Profita M, Gagliardo R, Di Giorgi R, Pompeo F, Gjomarkaj M, Nicolini G, Bousquet J, Vignola AM.
    Allergy; 2005 Mar; 60(3):323-9. PubMed ID: 15679717
    [Abstract] [Full Text] [Related]

  • 25. Early intervention of recent onset mild persistent asthma in children aged under 11 yrs: the Steroid Treatment As Regular Therapy in early asthma (START) trial.
    Chen YZ, Busse WW, Pedersen S, Tan W, Lamm CJ, O'Byrne PM.
    Pediatr Allergy Immunol; 2006 May; 17 Suppl 17():7-13. PubMed ID: 16573703
    [Abstract] [Full Text] [Related]

  • 26. Managing a variable disease.
    Kips J.
    Pulm Pharmacol Ther; 2002 May; 15(6):485-90. PubMed ID: 12493334
    [Abstract] [Full Text] [Related]

  • 27. Symbicort Turbuhaler: a new concept in asthma management.
    Kuna P, Kuprys I.
    Int J Clin Pract; 2002 Dec; 56(10):797-803. PubMed ID: 12510955
    [Abstract] [Full Text] [Related]

  • 28. Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid.
    Saleh D, Ernst P, Lim S, Barnes PJ, Giaid A.
    FASEB J; 1998 Aug; 12(11):929-37. PubMed ID: 9707165
    [Abstract] [Full Text] [Related]

  • 29. Inhaled corticosteroid therapy for patients with persistent asthma: learnings from studies of inhaled budesonide.
    Chipps BE.
    Allergy Asthma Proc; 2009 Aug; 30(3):217-28. PubMed ID: 19344546
    [Abstract] [Full Text] [Related]

  • 30. Effects of beclomethason/formoterol and budesonide/formoterol fixed combinations on lung function and airway inflammation in patients with mild to moderate asthma--an exploratory study.
    Kirsten AM, Watz H, Brindicci C, Piccinno A, Magnussen H.
    Pulm Pharmacol Ther; 2015 Apr; 31():79-84. PubMed ID: 25194884
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A health-related quality-of-life comparison of formoterol (Oxis) Turbuhaler plus budesonide (Pulmicort) Turbuhaler with budesonide Turbuhaler alone and noncorticosteroid treatment in asthma: a randomized clinical study in Russia.
    Chuchalin AG, Svensson K, Ståhl E, Ovcharenko SI, Goriachkina LA, Sidorenko IV, Tsoi AN, EPOCH Study Group.
    Respiration; 2002 Apr; 69(5):427-33. PubMed ID: 12232450
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Corticosteroid-induced gene expression in allergen-challenged asthmatic subjects taking inhaled budesonide.
    Kelly MM, King EM, Rider CF, Gwozd C, Holden NS, Eddleston J, Zuraw B, Leigh R, O'Byrne PM, Newton R.
    Br J Pharmacol; 2012 Mar; 165(6):1737-1747. PubMed ID: 21827450
    [Abstract] [Full Text] [Related]

  • 36. Difference in time-course of improvement in asthma control measures between budesonide and budesonide/formoterol.
    Matsunaga K, Kawabata H, Hirano T, Sugiura H, Minakata Y, Ichinose M.
    Pulm Pharmacol Ther; 2013 Apr; 26(2):189-94. PubMed ID: 23123925
    [Abstract] [Full Text] [Related]

  • 37. 24-h duration of the novel LABA vilanterol trifenatate in asthma patients treated with inhaled corticosteroids.
    Lötvall J, Bateman ED, Bleecker ER, Busse WW, Woodcock A, Follows R, Lim J, Stone S, Jacques L, Haumann B.
    Eur Respir J; 2012 Sep; 40(3):570-9. PubMed ID: 22362859
    [Abstract] [Full Text] [Related]

  • 38. The ICS/Formoterol Reliever Therapy Regimen in Asthma: A Review.
    Beasley R, Bruce P, Houghton C, Hatter L.
    J Allergy Clin Immunol Pract; 2023 Mar; 11(3):762-772.e1. PubMed ID: 36639054
    [Abstract] [Full Text] [Related]

  • 39. Efficacy of procaterol combined with inhaled budesonide for treatment of cough-variant asthma.
    Bao W, Chen Q, Lin Y, Liu H, Zhao G, Chen Z, Zhou X.
    Respirology; 2013 Nov; 18 Suppl 3():53-61. PubMed ID: 24188204
    [Abstract] [Full Text] [Related]

  • 40. Budesonide/formoterol maintenance and reliever therapy in primary care asthma management: effects on bronchial hyperresponsiveness and asthma control.
    Riemersma RA, Postma D, van der Molen T.
    Prim Care Respir J; 2012 Mar; 21(1):50-6. PubMed ID: 22015542
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.